Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
80.00
+1.14 (1.45%)
At close: Mar 19, 2026, 4:00 PM EDT
81.00
+1.00 (1.25%)
After-hours: Mar 19, 2026, 6:51 PM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $3.56 billion as of March 19, 2026. Its market cap has increased by 428.14% in one year.
Market Cap
3.56B
Enterprise Value
3.04B
1-Year Change
428.14%
Ranking
Category
Stock Price
$80.00
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $3.56B, an increase of 2,082.70%. That is a compound annual growth rate of 240.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 4.24B | 139.70% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.92B |
| Centessa Pharmaceuticals | 3.81B |
| Crinetics Pharmaceuticals | 3.75B |
| Corcept Therapeutics | 3.63B |
| ADMA Biologics | 3.58B |
| Structure Therapeutics | 3.57B |
| ACADIA Pharmaceuticals | 3.53B |
| NewAmsterdam Pharma Company | 3.50B |